193 related articles for article (PubMed ID: 8619718)
21. Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172).
Magnani HN
Thromb Haemost; 1993 Oct; 70(4):554-61. PubMed ID: 7509508
[TBL] [Abstract][Full Text] [Related]
22. Delayed thrombin generation with hirudin anticoagulation during prolonged cardiopulmonary bypass.
Rubens FD; Lavalee G; Ruel MA; Mesana T; Bourke M
Ann Thorac Surg; 2005 Jan; 79(1):334-6. PubMed ID: 15620975
[TBL] [Abstract][Full Text] [Related]
23. [Heparin-induced thrombocytopenia].
Depasse F; Samama MM
Ann Biol Clin (Paris); 2000; 58(3):317-26. PubMed ID: 10846236
[TBL] [Abstract][Full Text] [Related]
24. Heparinoid anticoagulation and topical fibrin sealant in heparin-induced thrombocytopenia.
Jackson MR; Danby CA; Alving BM
Ann Thorac Surg; 1997 Dec; 64(6):1815-7. PubMed ID: 9436582
[TBL] [Abstract][Full Text] [Related]
25. [Thrombosis of a cardiopulmonary bypass circuit despite recommended hypocoagulation with danaparoid during the acute phase of type II heparin-induced thrombocytopenia].
Salmi L; Elalamy I; Leroy-Matheron C; Houel R; Thébert D; Duvaldestin P
Ann Fr Anesth Reanim; 2006; 25(11-12):1144-8. PubMed ID: 17174213
[TBL] [Abstract][Full Text] [Related]
26. Treatment of heparin-induced thrombocytopenia.
Peters FP
J Thorac Cardiovasc Surg; 1997 Sep; 114(3):517-8. PubMed ID: 9305220
[No Abstract] [Full Text] [Related]
27. Management strategies for heparin-induced thrombocytopenia in heart-transplant candidates: case report and review of the literature.
Pamboukian SV; Ignaszewski AP; Ross HJ
J Heart Lung Transplant; 2000 Aug; 19(8):810-4. PubMed ID: 10967277
[TBL] [Abstract][Full Text] [Related]
28. Coronary artery bypass grafting in a patient with type II heparin associated thrombopenia.
Christiansen S; Geiger A; Splittgerber FH; Reidemeister JC
Cardiovasc Surg; 1998 Feb; 6(1):90-3. PubMed ID: 9546852
[TBL] [Abstract][Full Text] [Related]
29. Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia.
Hale LP; Smith K; Braden GA; Owen J
Cathet Cardiovasc Diagn; 1998 Nov; 45(3):318-22. PubMed ID: 9829897
[TBL] [Abstract][Full Text] [Related]
30. Management of heparin-induced thrombocytopenia during continuous renal replacement therapy.
Davenport A
Am J Kidney Dis; 1998 Oct; 32(4):E3. PubMed ID: 10074589
[TBL] [Abstract][Full Text] [Related]
31. Thromboembolic complications in a patient with heparin-induced thrombocytopenia (HIT) showing cross-reactivity to a low molecular weight heparin-treatment with Org 10172 (Lomoparan).
Muhm M; Claeys L; Huk I; Koppensteiner R; Kyrle PA; Minar E; Stümpflen A; Ehringer H; Polterauer P
Wien Klin Wochenschr; 1997 Feb; 109(4):128-31. PubMed ID: 9076930
[TBL] [Abstract][Full Text] [Related]
32. [Danaparoid (orgaran) for continuous venovenous hemodiafiltration in a patient with heparin-induced thrombocytopenia].
Christin F; Theissen-Laval O; Loeb JP
Ann Fr Anesth Reanim; 1998; 17(1):82-3. PubMed ID: 9750692
[No Abstract] [Full Text] [Related]
33. [Successful lysis of iliofemoral and inferior vena cava thrombi in heparin-induced type-II thrombocytopenia].
Emig U; Meyer T; Buchwald AB
Dtsch Med Wochenschr; 1997 Aug; 122(31-32):965-8. PubMed ID: 9280716
[TBL] [Abstract][Full Text] [Related]
34. Use of danaparoid sodium (Orgaran) as an alternative to heparin sodium during cardiopulmonary bypass: a clinical evaluation of six cases.
Fernandes P; Mayer R; MacDonald JL; Cleland AG; Hay-McKay C
Perfusion; 2000 Nov; 15(6):531-9. PubMed ID: 11131218
[TBL] [Abstract][Full Text] [Related]
35. [Thrombocytopenia due to heparin therapy. Use of danaparoid (Orgaran), 13 monocentric cases under authorization of temporary prescription (ATU)].
Gindre L; de Maistre E; Perrin A; Lecompte T; Hoffman MA
Therapie; 1997; 52(6):591-7. PubMed ID: 9734113
[TBL] [Abstract][Full Text] [Related]
36. Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass.
von Segesser LK; Mueller X; Marty B; Horisberger J; Corno A
Perfusion; 2001 Sep; 16(5):411-6. PubMed ID: 11565896
[TBL] [Abstract][Full Text] [Related]
37. Danaparoid thromboprophylaxis in pregnant women with heparin-induced thrombocytopenia.
Woo YL; Allard S; Cohen H; Letsky E; de Swiet M
BJOG; 2002 Apr; 109(4):466-8. PubMed ID: 12013171
[No Abstract] [Full Text] [Related]
38. Combined use of Orgaran and Reopro during coronary angioplasty in patients unable to receive heparin.
Cantor WJ; Leblanc K; Garvey B; Watson KR; Rasymas A; Strauss BH
Catheter Cardiovasc Interv; 1999 Mar; 46(3):352-5. PubMed ID: 10348139
[TBL] [Abstract][Full Text] [Related]
39. [Use of Orgaran for extracorporeal circulation in a patient allergic to heparin].
Bretelle C; Leude E; Quilici J; Vaillant A
Presse Med; 1996 Nov; 25(37):1846-7. PubMed ID: 8991040
[No Abstract] [Full Text] [Related]
40. [Sinus thrombosis in heparin-induced thrombocytopenia type II].
Schill D
Med Monatsschr Pharm; 2005 Jul; 28(7):253-4. PubMed ID: 16038130
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]